{
  "patient_information": "Age: 24 years Sex: female Residence: Peruvian Andes Travel history: recent travel to Lima, Peru Symptoms onset: 2 months ago Chief complaint: fever, weight loss (5 kg), nausea and vomiting Current symptoms: intermittent fevers for the past 2 weeks",
  "chief_complaint": "Acute onset of fever with abdominal pain over a period of two weeks.",
  "history_of_present_illness": "The patient reported that about 2 to 3 months ago she started taking over-the-counter medicines to lose weight and changed her diet to vegetarian food. She also reported the consumption of energetic hot drinks made from alfalfa and watercress. Prior to her current illness, she was healthy.",
  "exposure_and_epidemiology": "Travel history: recent travel to Lima, Peru Vector exposures: mosquito exposure is implied by the endemic setting Animal exposures: no animal exposures reported Water food risks: no water/food risks reported Contacts: no sick contacts reported Season outbreak context: no specific season or outbreak context provided",
  "vitals": "Temperature: 38.5°C (101.3°F) Blood pressure: 95/60 mmHg Heart rate: 105 bpm Respiratory rate: normal Oxygen saturation: normal",
  "physical_exam": "General appearance: ill appearance with pale mucous membranes but no jaundice Abdominal examination: right upper quadrant tenderness, liver slightly enlarged with a span of 15 cm Other systems: rest of the physical examination is normal",
  "labs_and_diagnostics": "Blood count: {\"WBC\": \"13.94 × 10^9/L (normal: 4–10)\", \"Eosinophils\": \"43% (<5%)\", \"Total eosinophil count\": \"5.97 <0.5\"} Hemoglobin: 12.3 g/dL (normal: 12–16) Liver function tests: {\"AST\": \"34 U/L (normal: 10–40)\", \"ALT\": \"55 U/L (normal: 7–40)\", \"AP\": \"170 U/L (normal: 20–126)\"} Amylase: 75 U/L (normal: 3–100) Lipase: 100 U/L (normal: 10–140) Liver imaging: {\"CT_scan\": \"hypodense non-enhancing hepatic lesions\"}",
  "differential_diagnosis": "['Fascioliasis', 'Pyogenic liver abscesses', 'Amoebic liver abscess', 'Other endemic infections in Peru with similar symptoms (e.g., brucellosis, visceral toxocariasis)']",
  "management_and_clinical_course": "Initial treatment: ceftriaxone and metronidazole for suspected pyogenic liver abscesses Clinical improvement: symptoms rapidly improved and laboratory parameters went back to normal Diagnostic confirmation: Fas2 ELISA titre was 0.56 (normal <0.2), supporting the suspected diagnosis of fascioliasis Treatment: single dose of triclabendazole 10 mg/kg Outcome: clinical improvement with full recovery by day 6; no complications documented",
  "final_diagnosis": "Disease name short: Fascioliasis Confirmation method: positive Fas2 ELISA titre Evidence: hypodense non-enhancing hepatic lesions on CT scan, eosinophilia, and travel history to Peru",
  "disease_name_short": null
}